CLDRP - 108 3849, WKG SOL, KODAK TECHNIDOL LIQUID DEVELOPER

  • MSDS: CLDRP
  • Manufacturer: EASTMAN KODAK COMPANY
  • Product Name: 108 3849, WKG SOL, KODAK TECHNIDOL LIQUID DEVELOPER
  • National Stock Number: 6750-01-387-8924
Product Identification

Product ID:108 3849, WKG SOL, KODAK TECHNIDOL LIQUID DEVELOPER
MSDS Date:03/17/2000
FSC:6750
NIIN:01-387-8924
Status Code:A
MSDS Number: CLDRP

Responsible Party
EASTMAN KODAK COMPANY
343 STATE ST
ROCHESTER, NY 14650
US

Emergency Phone: 716-722-5151

Info Phone: 800- 242-2424

Preparer: NOT PROVIDED

Cage: 19139

Contractor
EASTMAN KODAK CO GOVERNMENT MARKETS CONTRACTS
ROCHESTER, NY 14650-1115 US

Telephone: 716-722-5151/(800) 242-2424

Cage: 19139

Ingredients

WATER

CAS: 7732-18-5

RTECS: ZC0110000


DIETHYLENE GLYCOL

CAS: 111-46-6

RTECS: ID5950000

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED


DIETHANOLAMINE-SULFUR DIOXIDE COMPLEX

CAS: 63149-47-3

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED


TRIS(1-METHYLETHYL)NAPHTHALENE SULFONIC ACID SODIUM SALT

CAS: 1323-19-9

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED


HYDROQUINONE

CAS: 123-31-9

RTECS: MX3500000

OSHA PEL 2 MG/M3

ACGIH TLV: 2 MG/M3

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

Hazards

LD50 LC50 Mixture:NOT PROVIDED
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION: HARMFUL IF INHALED. EYES:
MAY BE IRRITATING. SKIN: MAY CAUSE ALLERGIC SKIN REACTION BASED ON
HUMAN EXPERIENCE. MAY CAUSE SKIN DEPIGMENTATION. PROLONGED OR
REPEATED CONTACT WITH AQUEOUS SOL UTIONS MAY CAUSE IRRITATION.
INGESTION: MAY BE FATAL IF SWALLOWED.
Explanation of Carcinogenicity:CARCINOGENICITY CLASSIFICATION
(COMPONENTS PRESENT AT 0.1% OR MORE): - INTERNATIONAL AGENCY FOR
RESEARCH ON CANCER (IARC): NONE - AMERICAN CONFERENCE OF
GOVERNMENTAL INDUSTRIAL HYGIENISTS (ACGIH): NON E - NATIONAL
TOXICOLOGY PROGRAM (NTP): NONE - OCCUPATIONAL SAFETY AND HEALTH
ADMINISTRATION (OSHA): NONE
Effects of Overexposure:EYES: MAY BE IRRITATING. SKIN: MAY CAUSE
ALLERGIC SKIN REACTION BASED ON HUMAN EXPERIENCE. MAY CAUSE SKIN
DEPIGMENTATION. PROLONGED OR REPEATED CONTACT WITH AQUEOUS
SOLUTIONS MAY CAUSE IRRITATION.
Medical Cond Aggravated by Exposure:NOT PROVIDED

First Aid

First Aid:INHALATION: IF SYMPTOMATIC, MOVE TO FRESH AIR. TREAT
SYMPTOMATICALLY. GET MEDICAL ATTENTION IF SYMPTOMS PERSIST. EYES:
ANY MATERIAL THAT CONTACTS THE EYE SHOULD BE WASHED OUT
IMMEDIATELY WITH WATER. GET MEDICAL ATTENTION IF SYMPTOMS OCCUR.
SKIN: WASH WITH SOAP AND WATER. GET MEDICAL ATTENTION IF SYMPTOMS
OCCUR. INGESTION: INDUCE VOMITING AS DIRECTED BY MEDICAL PERSONNEL.
NEVER GIVE ANYTHING BY MO UTH TO AN UNCONSCIOUS PERSON. CALL A
PHYSICIAN OR POISON CONTROL CENTER IMMEDIATELY.

Fire Fighting

Flash Point:NONE
Extinguishing Media:USE APPROPRIATE AGENT FOR ADJACENT FIRE.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
PROTECTIVE CLOTHING.
Unusual Fire/Explosion Hazard:NONE.

Accidental Release

Spill Release Procedures:FLUSH TO SEWER WITH LARGE AMOUNT OF WATER.
OTHERWISE, ABSORB SPILL WITH VERMICULITE OR OTHER INERT MATERIAL,
THEN PLACE IN A CONTAINER FOR CHEMICAL WASTE. CLEAN SURFACE
THOROUGHLY TO REMOVE RESIDUAL C ONTAMINATION.
Neutralizing Agent:NOT PROVIDED

Handling

Handling and Storage Precautions:KEEP CONTAINER CLOSED.
Other Precautions:AVOID PROLONGED OR REPEATED BREATHING OF MIST OR
VAPOR. AVOID CONTACT WITH EYES AND PROLONGED OR REPEATED CONTACT
WITH SKIN. USE WITH ADEQUATE VENTILATION. WASH THOROUGHLY AFTER
HANDLING.

Exposure Controls

Respiratory Protection:NONE SHOULD BE NEEDED.
Ventilation:GOOD GENERAL VENTILATION (TYPICALLY 10 AIR CHANGES PER
HOUR) SHOULD BE USED. VENTILATION RATES SHOULD BE MATCHED TO
CONDITIONS.
Protective Gloves:FOR PROLONGED OR REPEATED SKIN CONTACT, IMPERVIOUS
GLOVES SHOULD BE WORN.
Eye Protection:WEAR SAFETY GLASSES WITH SIDE SHIELDS (OR GOGGLES).
Other Protective Equipment:EYE BATH, WASHING FACILITIES, SAFETY SHOWER.
Work Hygienic Practices:IT IS A GOOD INDUSTRIAL HYGIENE PRACTICE TO
MINIMIZE EYE CONTACT. IT IS A GOOD INDUSTRIAL HYGIENE PRACTICE TO
MINIMIZE SKIN CONTACT.
Supplemental Safety and Health
ABBREVIATION: N/A = NOT APPLICABLE. N/AV = NOT AVAILABLE. N/K =
UNKNOWN. N/P = NOT PROVIDED. N/R = NOT RELEVANT. N/D = NOT
DETERMINED. N/E = NOT ESTABLISHED. CNS = CENTRAL NERVOUS SYSTEM. GI
= GASTROI NTESTINAL. SCBA = SELF CONTAINED BREATHING APPARATUS.

Chemical Properties

HCC:N1
NRC/State Lic Num:NOT RELEVANT
Boiling Pt:>100.C, 212.F
Melt/Freeze Pt:M.P/F.P Text:NOT PROVIDED
Decomp Temp:Decomp Text:NOT PROVIDED
Vapor Pres:18MM HHG @20C
Vapor Density:0.6
Spec Gravity:1.00-1.03
pH:8.8-8.9
Viscosity:NOT PROVIDED
Evaporation Rate & Reference:NOT PROVIDED
Solubility in Water:COMPLETE
Appearance and Odor:LIQUID, COLORLESS, ODORLESS.
Percent Volatiles by Volume:90-95 WT
Corrosion Rate:NOT PROVIDED

Stability

Stability Indicator/Materials to Avoid:YES
NONE WITH COMMON MATERIALS AND CONTAMINANTS WITH WHICH THE MATERIAL MAY
REASONABLY COME INTO CONTACT.
Stability Condition to Avoid:NOT PROVIDED
Hazardous Decomposition Products:NONE (NONCOMBUSTIBLE)

Disposal

Waste Disposal Methods:DISCHARGE, TREATMENT, OR DISPOSAL MAY BE SUBJECT
TO NATIONAL, STATE, OR LOCAL LAWS. FLUSH TO SEWER WITH LARGE AMOUNT
OF WATER. SINCE EMPTIED CONTAINERS RETAIN PRODUCT RESIDUE, FOLLOW
LABEL WARNINGS EV EN AFTER CONTAINER IS EMPTIED.

Toxicology

Toxicological Information:EFFECTS OF EXPOSURE: GENERAL:
CONTAINS: 1-PHENYL-4,4-DIMETHYL-3-PYRAZOLIDINONE BASED ON
REPEATED-DOSE INGESTION STUDIES IN ANIMALS,
1-PHENYL-4,4-DIMETHYL-3-PYRAZOLIDINONE, A MINOR C OMPONENT OF THIS
PRODUCT MAY CAUSE BLOOD, TESTICULAR, AND ADVERSE REPRODUCTIVE
EFFECTS. CONTAINS: DIETHYLENE GLYCOL. CAN CAUSE KIDNEY
DAMAGE. CAN CAUSE CNS EFFECTS. CONTAINS: HYDROQUIN ONE. IN
F-344 RATS, CHRONIC ORAL ADMINISTRATION OF HYDROQUINONE HAS
RESULTED IN THE FORMATION OF BENIGN KIDNEY TUMORS THOUGHT TO
BE SECONDARY TO NEPHROPATHY.

Other Information

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecology

Ecological:THE FOLLOWING PROPERTIES ARE ESTIMATED FROM THE COMPONENTS
OF THE PREPARATIONS. POTENTIAL TOXICITY: FISH LC50 MG/L: >100.
DAPHNID EC50 MG/L: 10-100. ALGAL IC50 MG/L: >100. ORGANICS
READILY DEGR ADABLE (>70%): YES (7 DAYS). POTENTIAL
BIOACCUMULATION: LOG POW <1. COD (APPROXIMATE G/L): 105. BOD5
(APPROXIMATE G/L): 10. POTENTIAL TOXICITY: WASTE TREATMENT
MICROORGANISMS EC50 (MG/L): NOT AVA ILABLE.

Transport

Transport Information:FOR TRANSPORTATION INFORMATION REGARDING THIS
PRODUCT CALL THE KODAK WORLDWIDE TRANSPORTATION HAZMAT HOT LINE:
(716) 722-2400 BETWEEN 8 A.M. AND 5 P.M. (EASTERN STANDARD TIME),
MONDAY THROUGH FRIDAY .

Regulatory

SARA Title III Information:CHEMICAL(S) SUBJECT TO THE REPORTING
REQUIREMENTS OF SECTION 313 OR TITLE III OF THE SUPERFUND
AMENDMENTS AND REAUTHORIZATION ACT (SARA) OF 1986 AND 40 CFR
PART 372: HYDROQUINONE
Federal Regulatory Information:NOT PROVIDED
State Regulatory Information:MATERIAL(S) KNOWN TO THE STATE OF
CALIFORNIA TO CAUSE CANCER: NONE - MATERIAL(S) KNOWN TO THE STATE
OF CALIFORNIA TO CAUSE ADVERSE REPRODUCTIVE EFFECTS: NONE